about
Reporting phenotypes in mouse models when considering body size as a potential confounderLinking rare and common disease: mapping clinical disease-phenotypes to ontologies in therapeutic target validationCLO: The cell line ontologyOAE: The Ontology of Adverse Events.Ontology-based combinatorial comparative analysis of adverse events associated with killed and live influenza vaccines.The Cell Ontology 2016: enhanced content, modularization, and ontology interoperability.Webulous and the Webulous Google Add-On--a web service and application for ontology building from templates.Linking MedDRA(®)-Coded Clinical Phenotypes to Biological Mechanisms by the Ontology of Adverse Events: A Pilot Study on Tyrosine Kinase Inhibitors.A bioinformatics analysis of the cell line nomenclatureOpen Targets: a platform for therapeutic target identification and validationUse of Biomedical Ontologies for Integration of Biological Knowledge for Learning and Prediction of Adverse Drug Reactions.Building bridges between cellular and molecular structural biology.The Cell Line Ontology and its use in tagging cell line names in biomedical text.Use of internet search logs to evaluate potential drug adverse events.Usage of cell nomenclature in biomedical literature.Cells in experimental life sciences - challenges and solution to the rapid evolution of knowledge.Comparison, alignment, and synchronization of cell line information between CLO and EFO.Ontological representation, integration, and analysis of LINCS cell line cells and their cellular responses.
P50
Q26766643-20CD4EAD-B625-4447-B405-23E457C5AB0CQ28602105-878E7142-2B8A-489F-8C89-85A7AF894ECFQ28650204-CD1834AA-423C-4823-A71F-714E1682B606Q33997761-CE2F63B0-F413-4ED4-9656-7E82E7D3C89BQ34499848-5DD74F99-3EB8-48F4-9F1B-4F8FF924B89DQ36067763-836AD3A5-A39C-4F80-B928-FF08EBD23D57Q36758657-7C118207-08A6-4723-83F7-0DBE33BA3872Q37066174-38AE17F5-691E-4A43-9918-059C3D754C73Q37090719-A12A6768-604A-43B3-A79E-44BF54E7AD0BQ37556749-EF3DEB17-7A8A-4B84-95FD-264B6E64E446Q38370993-64751E71-9DA8-4065-AE67-C38C87044A94Q38373358-DE54D3FB-15DC-4430-804E-6E2291360CE8Q38512786-539E8C80-7FD6-4F8E-89D3-FBF60BE6981CQ43482153-6D351ECC-37C9-4631-BF72-D9CA3888A7F2Q47565472-63BC5F4B-6EFB-454D-9196-EDBAB717F87BQ48519854-62482220-26D2-4FD9-95AD-06D5ED7A3767Q48542229-CAF83C5B-AD97-49A0-9B47-1D0D9A10BAE0Q49530386-321CFC24-3EAD-449A-85D5-3F3CEA924C8B
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Sirarat Sarntivijai
@ast
Sirarat Sarntivijai
@en
Sirarat Sarntivijai
@es
Sirarat Sarntivijai
@nl
Sirarat Sarntivijai
@sl
type
label
Sirarat Sarntivijai
@ast
Sirarat Sarntivijai
@en
Sirarat Sarntivijai
@es
Sirarat Sarntivijai
@nl
Sirarat Sarntivijai
@sl
altLabel
Sarntivijai S
@en
prefLabel
Sirarat Sarntivijai
@ast
Sirarat Sarntivijai
@en
Sirarat Sarntivijai
@es
Sirarat Sarntivijai
@nl
Sirarat Sarntivijai
@sl
P106
P2456
P31
P4012
P496
0000-0002-2548-641X